Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/JOP.2016.020503 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Merits of the social return on investment methodology for assessing the value of palliative care programmes.
Lancet Healthy Longev
January 2025
Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, USA. Electronic address:
Despite the widely accepted benefits of palliative care for individuals with serious illnesses and their families, the utilisation of this approach remains low. Although an increased use of palliative care services can increase the value of health-care spending by providing comprehensive wraparound services to support care, the economic evidence required to implement, promote, and engage in palliative care models on a wide scale eludes the affected individuals, health-care providers, payers, and policy makers. This gap in evidence is partly owing to the methodological limitations of standard value-assessment frameworks, which do not capture important societal dimensions of the value generated by palliative care.
View Article and Find Full Text PDFInvestigation of stakeholder perceptions of the wheelchair service delivery process.
Disabil Rehabil Assist Technol
January 2025
School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, Ohio, USA.
The wheelchair service delivery process (SDP) is a large complex system and therefore has many potential points of failure; determining priorities for improvement is challenging. The complexities introduce several barriers to accessing and maintaining wheelchairs for individuals with mobility impairments. Given the breadth and depth of the barriers, it is important to know in which areas to focus future policy reform efforts.
View Article and Find Full Text PDFIndividual application patterns of Cannabis-based Medicines in Germany - Descriptive evaluation of a patient survey and discussion from a forensic perspective.
Forensic Sci Int
December 2024
Department of Forensic Toxicology, Institute of Legal Medicine, University Medical Center, Am Pulverturm 3, Mainz D-55131, Germany. Electronic address:
Background: An increasing number of countries have legalised cannabis for medicinal purposes in recent years leading to tensions with other regulatory frameworks. Some countries grant a medical defence according to their drug driving legislations. This may lead to specific medico-legal assessments relating to the participation of cannabis patients in road traffic.
View Article and Find Full Text PDF[Vascular rehabilitation for patients with peripheral arterial occlusive disease].
Rehabilitation (Stuttg)
December 2024
Compared to patients with coronary heart disease, patients with PAD have a poorer attitude towards general practitioners with regard to the frequency of prescribing rehabilitative measures and controlling risk factors. The patients themselves do not perceive the increased cardiovascular risk and thus the need for lifestyle changes and compliance to the same extent as patients with coronary heart disease.The "Rehabilitation clinic with vascular expertise" certificate defines the criteria for fulfilling the specific structural and process requirements for vascular medicine.
View Article and Find Full Text PDFAn economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective.
BMC Health Serv Res
November 2024
Vincenz Hospital, Paderborn, Germany.
Background: Three recent randomized controlled trials demonstrated that, in patients with symptomatic paroxysmal atrial fibrillation (PAF), first-line pulmonary vein isolation with cryoballoon catheter ablation reduces atrial arrhythmia recurrence compared to initial antiarrhythmic drug (AAD) therapy. This study aimed to evaluate the cost-effectiveness of first-line cryoablation compared to first-line AADs from a German healthcare payer perspective.
Methods: Individual patient-level data from 703 participants with untreated PAF enrolled into three randomized clinical trials (Cryo-FIRST, STOP AF First and EARLY-AF) were used to derive parameters for the cost-effectiveness model (CEM).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!